38 research outputs found

    Powers of Hamilton cycles in pseudorandom graphs

    Full text link
    We study the appearance of powers of Hamilton cycles in pseudorandom graphs, using the following comparatively weak pseudorandomness notion. A graph GG is (ε,p,k,)(\varepsilon,p,k,\ell)-pseudorandom if for all disjoint XX and YV(G)Y\subset V(G) with Xεpkn|X|\ge\varepsilon p^kn and Yεpn|Y|\ge\varepsilon p^\ell n we have e(X,Y)=(1±ε)pXYe(X,Y)=(1\pm\varepsilon)p|X||Y|. We prove that for all β>0\beta>0 there is an ε>0\varepsilon>0 such that an (ε,p,1,2)(\varepsilon,p,1,2)-pseudorandom graph on nn vertices with minimum degree at least βpn\beta pn contains the square of a Hamilton cycle. In particular, this implies that (n,d,λ)(n,d,\lambda)-graphs with λd5/2n3/2\lambda\ll d^{5/2 }n^{-3/2} contain the square of a Hamilton cycle, and thus a triangle factor if nn is a multiple of 33. This improves on a result of Krivelevich, Sudakov and Szab\'o [Triangle factors in sparse pseudo-random graphs, Combinatorica 24 (2004), no. 3, 403--426]. We also extend our result to higher powers of Hamilton cycles and establish corresponding counting versions.Comment: 30 pages, 1 figur

    Mod/Resc Parsimony Inference

    Get PDF
    We address in this paper a new computational biology problem that aims at understanding a mechanism that could potentially be used to genetically manipulate natural insect populations infected by inherited, intra-cellular parasitic bacteria. In this problem, that we denote by \textsc{Mod/Resc Parsimony Inference}, we are given a boolean matrix and the goal is to find two other boolean matrices with a minimum number of columns such that an appropriately defined operation on these matrices gives back the input. We show that this is formally equivalent to the \textsc{Bipartite Biclique Edge Cover} problem and derive some complexity results for our problem using this equivalence. We provide a new, fixed-parameter tractability approach for solving both that slightly improves upon a previously published algorithm for the \textsc{Bipartite Biclique Edge Cover}. Finally, we present experimental results where we applied some of our techniques to a real-life data set.Comment: 11 pages, 3 figure

    Quantum phase transitions in superconducting arrays under external magnetic fields

    Full text link
    We study the zero-temperature phase transitions of two-dimensional superconducting arrays with both the self- and the junction capacitances in the presence of external magnetic fields. We consider two kinds of excitations from the Mott insulating phase: charge-dipole excitations and single-charge excitations, and apply the second-order perturbation theory to find their energies. The resulting phase boundaries are found to depend strongly on the magnetic frustration, which measures the commensurate-incommensurate effects. Comparison of the obtained values with those in recent experiment suggests the possibility that the superconductor-insulator transition observed in experiment may not be of the Berezinskii-Kosterlitz-Thouless type. The system is also transformed to a classical three-dimensional XY model with the magnetic field in the time-direction; this allows the analogy to bulk superconductors, revealing the nature of the phase transitions.Comment: 9 pages including 7 figures, to appear in Phys. Rev.

    Influence of thermal fluctuations on quantum phase transitions in one-dimensional disordered systems: Charge density waves and Luttinger liquids

    Full text link
    The low temperature phase diagram of 1D weakly disordered quantum systems like charge or spin density waves and Luttinger liquids is studied by a \emph{full finite temperature} renormalization group (RG) calculation. For vanishing quantum fluctuations this approach is amended by an \emph{exact} solution in the case of strong disorder and by a mapping onto the \emph{Burgers equation with noise} in the case of weak disorder, respectively. At \emph{zero} temperature we reproduce the quantum phase transition between a pinned (localized) and an unpinned (delocalized) phase for weak and strong quantum fluctuations, respectively, as found previously by Fukuyama or Giamarchi and Schulz. At \emph{finite} temperatures the localization transition is suppressed: the random potential is wiped out by thermal fluctuations on length scales larger than the thermal de Broglie wave length of the phason excitations. The existence of a zero temperature transition is reflected in a rich cross-over phase diagram of the correlation functions. In particular we find four different scaling regions: a \emph{classical disordered}, a \emph{quantum disordered}, a \emph{quantum critical} and a \emph{thermal} region. The results can be transferred directly to the discussion of the influence of disorder in superfluids. Finally we extend the RG calculation to the treatment of a commensurate lattice potential. Applications to related systems are discussed as well.Comment: 19 pages, 7 figure

    An ARPES view on the high-Tc problem: phonons vs spin-fluctuations

    Full text link
    We review the search for a mediator of high-Tc superconductivity focusing on ARPES experiment. In case of HTSC cuprates, we summarize and discuss a consistent view of electronic interactions that provides natural explanation of both the origin of the pseudogap state and the mechanism for high temperature superconductivity. Within this scenario, the spin-fluctuations play a decisive role in formation of the fermionic excitation spectrum in the normal state and are sufficient to explain the high transition temperatures to the superconducting state while the pseudogap phenomenon is a consequence of a Peierls-type intrinsic instability of electronic system to formation of an incommensurate density wave. On the other hand, a similar analysis being applied to the iron pnictides reveals especially strong electron-phonon coupling that suggests important role of phonons for high-Tc superconductivity in pnictides.Comment: A summary of the ARPES part of the Research Unit FOR538, http://for538.wmi.badw.d

    Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

    Get PDF
    Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10–14 and 50–54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2•72 (95% uncertainty interval [UI] 2•66–2•79) in 2000 to 2•31 (2•17–2•46) in 2019. Global annual livebirths increased from 134•5 million (131•5–137•8) in 2000 to a peak of 139•6 million (133•0–146•9) in 2016. Global livebirths then declined to 135•3 million (127•2–144•1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2•1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27•1% (95% UI 26•4–27•8) of global livebirths. Global life expectancy at birth increased from 67•2 years (95% UI 66•8–67•6) in 2000 to 73•5 years (72•8–74•3) in 2019. The total number of deaths increased from 50•7 million (49•5–51•9) in 2000 to 56•5 million (53•7–59•2) in 2019. Under-5 deaths declined from 9•6 million (9•1–10•3) in 2000 to 5•0 million (4•3–6•0) in 2019. Global population increased by 25•7%, from 6•2 billion (6•0–6•3) in 2000 to 7•7 billion (7•5–8•0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline. Globally, HALE increased from 58•6 years (56•1–60•8) in 2000 to 63•5 years (60•8–66•1) in 2019. HALE increased in 202 of 204 countries and territories between 2000 and 2019. Interpretation: Over the past 20 years, fertility rates have been dropping steadily and life expectancy has been increasing, with few exceptions. Much of this change follows historical patterns linking social and economic determinants, such as those captured by the GBD Socio-demographic Index, with demographic outcomes. More recently, several countries have experienced a combination of low fertility and stagnating improvement in mortality rates, pushing more populations into the late stages of the demographic transition. Tracking demographic change and the emergence of new patterns will be essential for global health monitoring. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

    Global burden of 87 risk factors in 204 countries and territories, 1990�2019: a systematic analysis for the Global Burden of Disease Study 2019

    Get PDF
    Background: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods: GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk�outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk�outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk�outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden. Findings: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10·8 million (95 uncertainty interval UI 9·51�12·1) deaths (19·2% 16·9�21·3 of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8·71 million (8·12�9·31) deaths (15·4% 14·6�16·2 of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253�350) DALYs (11·6% 10·3�13·1 of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0�9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10�24 years, alcohol use for those aged 25�49 years, and high systolic blood pressure for those aged 50�74 years and 75 years and older. Interpretation: Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens
    corecore